Embecta Corp. (EMBC) Form 8-K — May 15, 2026
$EMBCForm 8-KItems 2.01, 7.01, 9.01Filed May 15, 2026, 9:15 AM ET0000947871-26-000546Original filing
Embecta Corp. (EMBC) completed its acquisition of Owen Mumford Holdings Limited, a UK-based medical device innovator, for an upfront cash payment of £100 million. The deal also includes potential milestone payments of up to £50 million tied to sales of the Aidaptus® auto-injector platform through June 2029. This transaction accelerates Embecta’s strategic shift from a pure insulin delivery company to a broad-based medical supplies provider.
Key figures
- Deal Value Usd
- £150 million total (£100m upfront + £50m milestones)
- Milestone period
- through June 30, 2029
- Milestone payments
- up to £50 million
- Milestone condition
- sales of Aidaptus® next-generation auto-injector platform
- Upfront cash payment
- £100 million
Price after filing
1 day: 0.0%7 days: +5.7%30 days: -1.9%
Close on the filing date to close N calendar days later (from $3.14). Historical, not a forecast.
AI analysis
Red flags3 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.